chevrons

Back to Previous Page

Techcom Securities (TCX VN) – Q3 2026 – Net Profit Rises 13.2%

Summary of 9M 2026 results and outlook of Techcom Securities (TCX VN)

  • Net profit rose 13.2% y/y, driven by margin lending and investment banking (IB), which together contribute around 73% of operating income. Margin lending surged 51.9% y/y on a larger loan book funded by last year’s IPO capital and a growing client base, while IB grew 35.7% y/y as corporate bond issuance volume doubled, more than offsetting slightly lower fees. These gains outweighed weakness in other segments: distribution and treasury income fell 30.6% y/y as TCX narrowed its distribution spread to offer more competitive pricing to investors amid elevated bank deposit rates. Brokerage income also softened on weaker market-wide trading. Cost discipline remained a key strength, with a cost-to-income ratio of just 8.1%.
  • Funding diversification keeps the balance sheet healthy. Amid tight liquidity in Vietnam’s banking system, the company has increasingly turned to overseas borrowings, which now account for 54% of total debt and are fully hedged (FX and rates). The debt-to-equity ratio eased to 1.0x, below the peer average of 1.4x, and margin lending was well below 200%-of-equity regulatory ceiling, leaving room to grow.
  • Industry tailwinds should build into 2027. Deposit rates should moderate slightly as inflation eases and funding from international markets rises, though strong credit demand limits the room for cuts. Corporate bond issuance is forecast to grow 20% in 2027 as corporates increasingly tap the bond market, which at just 10.6% of GDP retains ample headroom. In equities, attractive valuations (10.0x forward P/E ex-Vingroup) and FTSE emerging-market inclusion should lift trading activity. Vietnam’s first investment-grade rating (R&I, October 2026) should also facilitate capital raising activities for both equity and debt markets.
  • We expect Q4/2026 Corporate bond issuance should stay robust on refinancing needs, and a larger margin loan book should continue to support earnings. Conversely, high deposit rates are likely to keep weighing on brokerage and bond distribution income.
  • For 2027, the key swing factor is distribution and treasury, which should rebound by around 47% as a moderation in deposit rates restores bond spreads and investor demand. IB and margin lending growth will be supported by sustained issuance demand from Techcombank’s corporate clients and a growing loan book. Brokerage should also recover alongside market activity.

Interested in TCX? Click here to read more of our previous analysis on TCX’s quarterly earnings.

Company ratings and target prices are accessible for clients only.

If you are interested in getting full access to our paid Primary Research Materials feel free to get in touch with us at your convenience.

Our team is actively covering 50 companies in the listed Vietnamese equity space for our clients.

Photo image credit: Techcombank

 

Related News & Insights
Find out more navigation_button
news

Summary of 9M 2026 results and outlook of Techcom Securities (TCX VN) Net profit rose 13.2% y/y, driven by margin lending and investment banking (IB), which together contribute around 73% of operating income. Margin lending surged 51.9% y/y on a larger loan book funded by last year’s IPO capital and a growing client base, while […]

Read Newsarrow
news

Summary of 9M 2026 results and outlook of Techcombank (TCB VN) Net profit rose 21.3% y/y on solid credit expansion, gradual margin recovery and a stronger contribution from fee income. Total credit grew 19.4% y/y, led by corporate lending on infrastructure-related financing demand from major national projects and strong demand across trading and manufacturing sectors. […]

Read Newsarrow
news

Summary of H1 2026 results and outlook of Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD VN) Earnings remained broadly flat, reflecting a short-term period of increasing competition in key categories, particularly oncology and antibiotics, temporary delays in public-hospital tender activity following provincial mergers in mid-2025, and a slower-than-expected pace of new-product launches as DBD […]

Read Newsarrow
Find out more navigation_button